Projects funded by the NCN

Impact of nanoparticles on cancer metastasis - epigenetic mechanisms

Call: OPUS 8 , Panel: NZ7

Principal investigator: prof. Marcin Kruszewski

Wyższa Szkoła Informatyki i Zarządzania w Rzeszowie, Wydział Medyczny

Identification of molecular events connected with development, growing and expansion of neuronal and mixed neuronal-glia...

Call: OPUS 8 , Panel: NZ4

Principal investigator: dr hab. Magdalena Zakrzewska

Uniwersytet Medyczny w Łodzi, Wydział Lekarski

Development of hyphenated analytical (capillary electrophoresis-inductively coupled plasma mass spectrometry) methodolog...

Call: PRELUDIUM 6 , Panel: ST4

Principal investigator: Magdalena Matczuk

Politechnika Warszawska, Wydział Chemiczny

Analysis of the effect of the DIS3 mutations on the viability, development and tumor formation in mice

Call: HARMONIA 5 , Panel: NZ4

Principal investigator: dr hab. Andrzej Dziembowski

Instytut Biochemii i Biofizyki PAN

Development of analytical methods for investigation of ionomic equilibrium in tumour cells under the exposure of metallo...

Call: OPUS 5 , Panel: ST4

Principal investigator: dr hab. Katarzyna Pawlak

Politechnika Warszawska, Wydział Chemiczny

Cannabidiol as a modulator of radiological response in the therapy of peripheral nervous system tumors - lipidomics from...

Call: SONATA 19 , Panel: ST4

Principal investigator: dr Karolina Chrabąszcz

Instytut Fizyki Jądrowej im. Henryka Niewodniczańskiego Polskiej Akademii Nauk

Design and Development of Serine Hydroxymethyltransferase-2 (SHMT2) Inhibitors Blocking Tumor Growth

Call: SONATA BIS 13 , Panel: NZ7

Principal investigator: dr hab. Miłosz Ruszkowski

Instytut Chemii Bioorganicznej Polskiej Akademii Nauk

Development of novel bifunctional ceramic coatings with osteoinductive and anti-oncogenic properties on metallic implant...

Call: PRELUDIUM 22 , Panel: ST5

Principal investigator: Balbina Makurat-Kasprolewicz

Politechnika Gdańska

3D-printed bone implants - Exploring the relationship between the chemical and spatial structure of implants and their s...

Call: OPUS 25 , Panel: ST4

Principal investigator: prof. Edyta Proniewicz

Akademia Górniczo-Hutnicza im. Stanisława Staszica w Krakowie, Wydział Odlewnictwa

Molecular insights into hypoxic tumors – for development of targeted cancer therapeutics

Call: POLONEZ BIS 3 , Panel: NZ5

Principal investigator: dr Marco Deiana

Politechnika Wrocławska

Three-dimensional mass spectrometry imaging system (3D MSI)

Call: SONATA BIS 12 , Panel: ST4

Principal investigator: dr hab. Joanna Nizioł

Politechnika Rzeszowska im. Ignacego Łukasiewicza, Wydział Chemiczny

Development of biomaterial-assisted tissue-engineered healthy and malignant bone tissue model to study osteosarcoma cell...

Call: PRELUDIUM 20 , Panel: ST5

Principal investigator: Ewa Walejewska

Politechnika Warszawska, Wydział Inżynierii Materiałowej

Structural characterization of metallothionein zinc-loaded states and their role in regulation of p53 tumor supressor ac...

Call: ETIUDA 8 , Panel: ST4

Principal investigator: Manuel Peris Diaz

Uniwersytet Wrocławski, Wydział Biotechnologii

Role of ferroptotic cancer cells in tumour development through modulation of the tumour microenvironment

Call: SONATA 15 , Panel: NZ5

Principal investigator: dr Paulina Kucharzewska-Siembieda

Szkoła Główna Gospodarstwa Wiejskiego w Warszawie

Elucidating the role of erythroid progenitor cells (EPCs) in the development of antibacterial immune response in the cou...

Call: OPUS 18 , Panel: NZ6

Principal investigator: prof. Dominika Nowis

Warszawski Uniwersytet Medyczny, Wydział Lekarski

NANOS1 RNP-interactome: structure and dynamics during specification/early stages of human germ cell development - signif...

Call: OPUS 18 , Panel: NZ1

Principal investigator: prof. Jadwiga Jaruzelska

Instytut Genetyki Człowieka Polskiej Akademii Nauk

DEVELOPMENT OF NEW CLASS PHOTOACTIVATED ANTICANCER-ANTIFUNGAL COMPOUNDS: CONJUGATES OF GOLD NANOPARTICLE-SUPPORTED QUINO...

Call: OPUS 17 , Panel: NZ7

Principal investigator: dr hab. Oleh Demchuk

Sieć Badawcza ŁUKASIEWICZ - Instytut Farmaceutyczny

The applicability of Coated Blade Spray coupled with mass spectrometry for the analysis endogenous substances in meningi...

Call: PRELUDIUM 17 , Panel: ST4

Principal investigator: Joanna Bogusiewicz

Uniwersytet Mikołaja Kopernika w Toruniu, Collegium Medicum im. Ludwika Rydygiera w Bydgoszczy, Wydział Farmaceutyczny

Anticancer Trojan horses: Application of the bioconjugation idea to invent new anticancer drugs

Call: UWERTURA 3 , Panel: ST4

Principal investigator: dr Michał Antoszczak

Uniwersytet im. Adama Mickiewicza w Poznaniu, Wydział Chemii

The role of metallothionein zinc-load states in regulation of p53 tumor supressor activity

Call: PRELUDIUM 16 , Panel: ST4

Principal investigator: Manuel Peris Diaz

Uniwersytet Wrocławski, Wydział Biotechnologii

Multimodal gold nanoparticles as potential radiopharmaceuticals in targeted radionuclide therapy

Call: SONATA 14 , Panel: ST4

Principal investigator: dr Agnieszka Majkowska-Pilip

Instytut Chemii i Techniki Jądrowej

The role of MCPIP1 as a potential tumor suppressor during development and treatment of clear cell renal cell carcinoma

Call: PRELUDIUM 13 , Panel: NZ5

Principal investigator: dr Paulina Marona

Uniwersytet Jagielloński, Wydział Biochemii, Biofizyki i Biotechnologii

Microfluidic SERS-based analysis of circulating tumor cells (CTCs) from blood samples - new diagnostic approach for "liq...

Call: OPUS 13 , Panel: ST4

Principal investigator: dr hab. Agnieszka Michota-Kamińska

Instytut Chemii Fizycznej Polskiej Akademii Nauk

The role of interferon lambda (IFN-L) in development of immunological anti-tumour mechanizm during proggression of canin...

Call: SONATA 12 , Panel: NZ5

Principal investigator: dr Joanna Mucha

Szkoła Główna Gospodarstwa Wiejskiego w Warszawie, Instytut Medycyny Weterynaryjnej

New analytical solutions in oncology: from basic research to rapid intraoperative diagnostics

Call: HARMONIA 7 , Panel: ST4

Principal investigator: dr hab. Barbara Bojko

Uniwersytet Mikołaja Kopernika, Collegium Medicum im. Ludwika Rydygiera w Bydgoszczy, Wydział Farmaceutyczny